The message in the compulsory licence granted to Natco Pharma to sell a generic version of patented cancer drug Nexavar appears to have hit home.
Section: Money | Tuesday, May 22, 2012 9:28 IST
By acquiring DRG, a US-based healthcare information provider, Piramal Healthcare is venturing into a field where no major Indian pharma player has tread so far.
Section: Money | Thursday, May 17, 2012 8:36 IST
Priyanka Golikeri calls for restraint, who finds these freebies causing more harm than good in the ultimate analysis.
Section: Money | Wednesday, May 16, 2012 10:00 IST
That lays to rest fears regarding the drugmaker’s deal with Israel’s Teva to market it in the US.
Section: Money | Thursday, May 10, 2012 8:30 IST
GSK Pharma, which came short of estimates in the March quarter, is optimistic about growing in line with the overall pharma industry.
Section: Money | Wednesday, May 9, 2012 9:19 IST
In-house brands are racking up a double-digit growth, propelled by low rates. Buyers don’t mind going for them as long as the products serve their purpose.
Section: Money | Wednesday, May 9, 2012 9:00 IST
The draft policy on pricing of pharmaceuticals, which health activists claimed could have raised prices of medicines rather than lowered them, has been swept under the carpet.
Section: Money | Monday, May 7, 2012 8:45 IST
Unlike the 11-13% average hikes predicted by salary surveys a few months ago, the ground reality points to 4-10% across sectors.
Section: India | Friday, May 4, 2012 8:00 IST
Jobless freshers seem to be taking the adage ‘something is better than nothing’ seriously.
Section: India | Tuesday, May 1, 2012 8:00 IST
Industry experts said the drugs come under the novel drug delivery systems, or NDDS, category. They are easier to administer, need lesser dosage and thus help improve patient compliance.
Section: Money | Thursday, April 26, 2012 9:00 IST
|
Archive page 1 of 74 |
 |
